重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
15期
2028-2030
,共3页
张敏%刘晓君%罗成%陈开杰%孔令希%何海霞%周远大
張敏%劉曉君%囉成%陳開傑%孔令希%何海霞%週遠大
장민%류효군%라성%진개걸%공령희%하해하%주원대
痰热清注射液%左氧氟沙星%高效液相色谱%分布
痰熱清註射液%左氧氟沙星%高效液相色譜%分佈
담열청주사액%좌양불사성%고효액상색보%분포
Tanreqing Injection%levofloxacin%HPLC%distribution
目的:探讨痰热清注射液对左氧氟沙星在小鼠肺组织中分布的影响。方法将144只小鼠分为痰热清注射液联合左氧氟沙星实验组和左氧氟沙星对照组,两组动物分别于0.05、0.083、0.17、0.5、1.0、2.0、4.0、8.0h和12.0h采集肺组织,制为匀浆,高效液相色谱法检测肺组织中左氧氟沙星药物浓度,3 P97程序计算药动学参数。结果实验组和对照组肺组织中药‐时曲线呈二室模型,实验组和对照组肺组织中V/Ft1/2β、CL ,AUCo‐t分别为(1.37±0.30 vs .1.90±0.24)L、(5.21±1.96 vs .4.82±1.55)h、(0.81±0.12 vs .1.13±0.14)L/h和(117.69±22.89 vs .84.91±11.33)mg · h-1· kg -1,组间差异有统计学意义(P<0.05)。表明痰热清注射液能提高左氧氟沙星在小鼠肺组织中的分布量和滞留时间。结论痰热清注射液联合左氧氟沙星可提高左氧氟沙星在小鼠肺组织中的药物浓度并延长滞留时间长。
目的:探討痰熱清註射液對左氧氟沙星在小鼠肺組織中分佈的影響。方法將144隻小鼠分為痰熱清註射液聯閤左氧氟沙星實驗組和左氧氟沙星對照組,兩組動物分彆于0.05、0.083、0.17、0.5、1.0、2.0、4.0、8.0h和12.0h採集肺組織,製為勻漿,高效液相色譜法檢測肺組織中左氧氟沙星藥物濃度,3 P97程序計算藥動學參數。結果實驗組和對照組肺組織中藥‐時麯線呈二室模型,實驗組和對照組肺組織中V/Ft1/2β、CL ,AUCo‐t分彆為(1.37±0.30 vs .1.90±0.24)L、(5.21±1.96 vs .4.82±1.55)h、(0.81±0.12 vs .1.13±0.14)L/h和(117.69±22.89 vs .84.91±11.33)mg · h-1· kg -1,組間差異有統計學意義(P<0.05)。錶明痰熱清註射液能提高左氧氟沙星在小鼠肺組織中的分佈量和滯留時間。結論痰熱清註射液聯閤左氧氟沙星可提高左氧氟沙星在小鼠肺組織中的藥物濃度併延長滯留時間長。
목적:탐토담열청주사액대좌양불사성재소서폐조직중분포적영향。방법장144지소서분위담열청주사액연합좌양불사성실험조화좌양불사성대조조,량조동물분별우0.05、0.083、0.17、0.5、1.0、2.0、4.0、8.0h화12.0h채집폐조직,제위균장,고효액상색보법검측폐조직중좌양불사성약물농도,3 P97정서계산약동학삼수。결과실험조화대조조폐조직중약‐시곡선정이실모형,실험조화대조조폐조직중V/Ft1/2β、CL ,AUCo‐t분별위(1.37±0.30 vs .1.90±0.24)L、(5.21±1.96 vs .4.82±1.55)h、(0.81±0.12 vs .1.13±0.14)L/h화(117.69±22.89 vs .84.91±11.33)mg · h-1· kg -1,조간차이유통계학의의(P<0.05)。표명담열청주사액능제고좌양불사성재소서폐조직중적분포량화체류시간。결론담열청주사액연합좌양불사성가제고좌양불사성재소서폐조직중적약물농도병연장체류시간장。
Objective To investigate the effects of Tanreging Injection on the distribution of levofloxacin in the lung tissue of mice .Methods 144 mice were randomily divided into the levofloxacin experimental group and the levofloxacin control group ,72 ca‐ses in each group .The experimental group was injected by Tanreqing Injection 0 .8 mg/kg and the control group was injected by the same volume of normal saline .The mice in the two groups were sacrificed for collecting the lung tissues at the time points of 0 .05 , 0 .08 ,0 .17 ,0 .5 ,1 .0 ,2 .0 ,4 .0 ,8 .0 ,12 h and preparing the homogenate .The levofloxacin concentration in the lung tissue was deter‐mined by HPLC and the pharmacokinetic parameters were calculated by the 3P97 program .Results The concentration curves based on drug‐time in the experimental group and the control group both fitted the two‐compartments model .The main pharmacokinetic parameters in the lung tissue V/Ft1/2β,CL ,AUCo‐t were (1 .37 ± 0 .30 vs .1 .90 ± 0 .24)L ,(5 .21 ± 1 .96 vs .4 .82 ± 1 .55) h ,(0 .81 ± 0 .12 vs .1 .13 ± 0 .14)L/h and (117 .69 ± 22 .89 vs .84 .91 ± 11 .33) mg · h-1 · kg -1 respectively ,the differences between the two groups were statistically significant (P<0 .05) .The results indicated that Tanreqing Injection increased the distribution amount of levofloxaction and residence time in the lung tissue of mice .Conclusion The combained of Tanreqing Injection and levofloxacin can increase the g concentration and residence time of levofloxacin in the lung tissue of mice .